https://www.selleckchem.com/products/BKM-120.html
We aimed to test our expectation that additional administration of Traditional Chinese medicine (TCM), maxingshigan-weijing decoction, is more effective in the management of COVID-19 patients compared to those treated with routine supportive care alone. This is a multicenter, open-label 2-arm (11 ratio) randomized controlled trial. Patients will be recruited from 3 hospitals in Wenzhou China the First Affiliated Hospital of Wenzhou Medical University, the Second Affiliated Hospital of Wenzhou Medical University and Wenzhou Center Hospit
Like
Comment
Share
